A meta-analysis of 17 studies with various carcinomas uncovered the role of miR-21 (an oncomiR known to promote EMT through TGFβ pathway) as a poor prognosis biomarker in breast, squamous cell carcinoma, astrocytoma, and gastric cancer [64]. The gene discussed is TGFB1; the disease is carcinoma.